The role of kidney-pancreas transplantation in diabetic kidney disease.
For patients with type 1 diabetes, innovations in insulin formulations and delivery have improved the ability to achieve excellent blood glucose control. However, it is uncommon to achieve euglycemia, particularly while avoiding complications arising from hypoglycemia. Pancreas transplantation remains the only broadly applied treatment strategy that can result in normalization of blood glucose, but this must be weighed against the risks of a surgical procedure and subsequent immunosuppression. To improve this risk/benefit ratio, pancreas transplantation is typically performed in patients with kidney failure who are to undergo kidney transplantation and immunosuppression (simultaneous pancreas-kidney transplant) or who have undergone kidney transplant and are obligated to the use of immunosuppressive medications (pancreas after kidney transplant). The purpose of this review is to clarify the benefit of an added pancreas transplant in these clinical settings and formulate an approach to the patient with type 1 diabetes as they approach kidney failure.
Wiseman
Alexander C
AC
Transplant Center, University of Colorado Denver, 1635 North Aurora Court, Aurora, CO 80045, USA. Alexander.wiseman@ucdenver.edu
D003928:Diabetic Nephropathies / Q000150:complications / Q000628:therapy*; D019317:Evidence-Based Medicine; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation; D016035:Pancreas Transplantation; D016019:Survival Analysis